Celltrion
068270.KS
#808
Rank
ยฃ19.34 B
Marketcap
ยฃ93.39
Share price
0.73%
Change (1 day)
-3.48%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - Total debt

Total debt on the balance sheet as of March 2024 : ยฃ1.27 Billion

According to Celltrion 's latest financial reports the company's total debt is ยฃ1.27 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Celltrion - Total debt on balance sheet (from 2007 to 2024)

Total debt by year

Year Total debt Change
2022-12-31ยฃ0.51 B12.08%
2021-12-31ยฃ0.46 B-11.38%
2020-12-31ยฃ0.52 B60.07%
2019-12-31ยฃ0.32 B-10.39%
2018-12-31ยฃ0.36 B-18.05%
2017-12-31ยฃ0.44 B-2.55%
2016-12-31ยฃ0.45 B-0.09%
2015-12-31ยฃ0.45 B-7.85%
2014-12-31ยฃ0.49 B15.04%
2013-12-31ยฃ0.43 B20.71%
2012-12-31ยฃ0.35 B54.33%
2011-12-31ยฃ0.23 B46.36%
2010-12-31ยฃ0.15 B18.4%
2009-12-31ยฃ0.13 B4.78%
2008-12-31ยฃ0.12 B759.91%
2007-12-31ยฃ14.81 M